New outreach aims to close smoking cessation gap for BIPOC communities
NCT ID NCT05671380
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a proactive, culturally tailored outreach program to help BIPOC adults who smoke quit tobacco. Researchers will enroll 700 participants from two health systems and provide personalized materials and support to connect them with proven cessation treatments. The goal is to see if this approach increases quit rates and reduces tobacco-related heart disease disparities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Longitudinal Proactive Outreach (behavioral intervention)
What this could lead to
If successful, this approach could provide an effective, scalable way to help BIPOC smokers quit, reducing tobacco-related heart disease in these communities.
What could go wrong
This is a pragmatic trial testing a behavioral intervention, not a new drug or cure. Success depends on participants' engagement, and results may not apply to all populations or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hennepin Healthcare
Minneapolis, Minnesota, 55415, United States
-
Mayo Clinic Health System
Rochester, Minnesota, 55902, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States